ASX - By Stock
|
CU6 |
Re:
Ann: Change of Director's Interest Notice - Rob Thomas
|
|
Bran
|
8 |
3.5K |
14 |
23/05/24 |
23/05/24 |
ASX - By Stock
|
8
|
3.5K
|
14
|
|
ASX - By Stock
|
CU6 |
Re:
Ann: Successful Completion of Retail Entitlement Offer
|
|
Bran
|
5 |
2.3K |
4 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
5
|
2.3K
|
4
|
|
ASX - By Stock
|
CU6 |
Re:
Industry News: A competitor just got bought out!
|
|
Bran
|
16 |
5.1K |
9 |
20/03/24 |
20/03/24 |
ASX - By Stock
|
16
|
5.1K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
ASH2023 - Sheba 2.0
|
|
Bran
|
156 |
53K |
3 |
03/11/23 |
03/11/23 |
ASX - By Stock
|
156
|
53K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Zantrene data published in Cancer Research Journal
|
|
Bran
|
38 |
14K |
138 |
21/06/22 |
21/06/22 |
ASX - By Stock
|
38
|
14K
|
138
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Oncology Announces On-Market Share Buyback
|
|
Bran
|
215 |
74K |
65 |
09/06/22 |
09/06/22 |
ASX - By Stock
|
215
|
74K
|
65
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Expanded Heart Protection Discovery for Zantrene
|
|
Bran
|
386 |
136K |
34 |
08/12/21 |
08/12/21 |
ASX - By Stock
|
386
|
136K
|
34
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Ceasing to be a substantial holder
|
|
Bran
|
40 |
12K |
35 |
29/11/21 |
29/11/21 |
ASX - By Stock
|
40
|
12K
|
35
|
|
ASX - By Stock
|
RAC |
Re:
SPP Survey
|
|
Bran
|
314 |
93K |
2 |
28/11/21 |
28/11/21 |
ASX - By Stock
|
314
|
93K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
SPP Survey
|
|
Bran
|
314 |
93K |
5 |
28/11/21 |
28/11/21 |
ASX - By Stock
|
314
|
93K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
Bran
|
218 |
67K |
18 |
24/11/21 |
24/11/21 |
ASX - By Stock
|
218
|
67K
|
18
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Bran
|
22K |
7.9M |
7 |
07/10/21 |
07/10/21 |
ASX - By Stock
|
22K
|
7.9M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race appoints Professor Michael Kelso as Principal Scientist
|
|
Bran
|
24 |
7.1K |
16 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
24
|
7.1K
|
16
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Bisantrene Preclinical Drug Study Published
|
|
Bran
|
83 |
28K |
30 |
10/05/21 |
10/05/21 |
ASX - By Stock
|
83
|
28K
|
30
|
|
ASX - By Stock
|
RAC |
Re:
Race- Buyout or Takeover discussions
|
|
Bran
|
92 |
31K |
13 |
03/05/21 |
03/05/21 |
ASX - By Stock
|
92
|
31K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates Extramedullary AML Preclinical Study
|
|
Bran
|
145 |
40K |
17 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
145
|
40K
|
17
|
|
ASX - By Stock
|
GNM |
Re:
Ann: Capital Raising to accelerate Camel Creek exploration
|
|
Bran
|
24 |
11K |
7 |
25/03/21 |
25/03/21 |
ASX - By Stock
|
24
|
11K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Cleansing Notice
|
|
Bran
|
104 |
25K |
22 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
104
|
25K
|
22
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Compelling Preclinical Breast Cancer Results
|
|
Bran
|
253 |
85K |
41 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
253
|
85K
|
41
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Compelling Preclinical Breast Cancer Results
|
|
Bran
|
253 |
85K |
26 |
09/03/21 |
09/03/21 |
ASX - By Stock
|
253
|
85K
|
26
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Bran
|
11K |
4.1M |
5 |
26/02/21 |
26/02/21 |
General
|
11K
|
4.1M
|
5
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Bran
|
22K |
7.9M |
19 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
22K
|
7.9M
|
19
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race to recruit new Chief Medical Officer
|
|
Bran
|
93 |
23K |
5 |
19/02/21 |
19/02/21 |
ASX - By Stock
|
93
|
23K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
3.0K |
1.0M |
5 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
3.0K
|
1.0M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
3.0K |
1.0M |
2 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
3.0K
|
1.0M
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
3.0K |
1.0M |
7 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
3.0K
|
1.0M
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
3.0K |
1.0M |
5 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
3.0K
|
1.0M
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
3.0K |
1.0M |
12 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
3.0K
|
1.0M
|
12
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
3.0K |
1.0M |
4 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
3.0K
|
1.0M
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
3.0K |
1.0M |
14 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
3.0K
|
1.0M
|
14
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
3.0K |
1.0M |
6 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
3.0K
|
1.0M
|
6
|
|
ASX - By Stock
|
RAC |
Re:
Pillar 1 - FTO (new thread)
|
|
Bran
|
3.0K |
1.0M |
6 |
17/02/21 |
17/02/21 |
ASX - By Stock
|
3.0K
|
1.0M
|
6
|
|
ASX - By Stock
|
RAC Biotech |
Re:
RAC - Charts & Price Action
|
|
Bran
|
22K |
7.9M |
36 |
12/02/21 |
12/02/21 |
ASX - By Stock
|
22K
|
7.9M
|
36
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Bran
|
1.1K |
321K |
7 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
321K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Bran
|
1.1K |
321K |
4 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
321K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Low Back Pain Results
|
|
Bran
|
1.1K |
321K |
4 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
1.1K
|
321K
|
4
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Bran
|
11K |
4.1M |
25 |
10/02/21 |
10/02/21 |
General
|
11K
|
4.1M
|
25
|
|
ASX - By Stock
|
RAC |
Re:
RAC Upside - promising forgotten cancer drug that works
|
|
Bran
|
208 |
100K |
11 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
208
|
100K
|
11
|
|
ASX - By Stock
|
RAC |
Re:
Congrats!
|
|
Bran
|
6 |
2.2K |
7 |
17/12/20 |
17/12/20 |
ASX - By Stock
|
6
|
2.2K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
The RAC 3-Pillar Trifecta
|
|
Bran
|
424 |
159K |
7 |
06/12/20 |
06/12/20 |
ASX - By Stock
|
424
|
159K
|
7
|
|
General
|
RAC |
Re:
General Comments / Chat
|
|
Bran
|
11K |
4.1M |
15 |
01/12/20 |
01/12/20 |
General
|
11K
|
4.1M
|
15
|
|
ASX - By Stock
|
RAC |
Re:
RAC Research Primer - June 2020
|
|
Bran
|
141 |
37K |
7 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
141
|
37K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Extension of time to repay loan through share buy-back
|
|
Bran
|
27 |
7.4K |
4 |
17/06/20 |
17/06/20 |
ASX - By Stock
|
27
|
7.4K
|
4
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Trading Halt
|
|
Bran
|
151 |
40K |
3 |
15/06/20 |
15/06/20 |
ASX - By Stock
|
151
|
40K
|
3
|
|
ASX - By Stock
|
ADN |
Re:
Ann: Trading Halt
|
|
Bran
|
159 |
89K |
2 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
159
|
89K
|
2
|
|
ASX - By Stock
|
NUH |
Re:
Ann: NUH Partners with Walgreens in US Direct-to-Consumer Hearing
|
|
Bran
|
170 |
82K |
18 |
16/12/19 |
16/12/19 |
ASX - By Stock
|
170
|
82K
|
18
|
|
ASX - By Stock
|
NUH |
Re:
Ann: NUH Partners with Walgreens in US Direct-to-Consumer Hearing
|
|
Bran
|
170 |
82K |
9 |
16/12/19 |
16/12/19 |
ASX - By Stock
|
170
|
82K
|
9
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 3Y-Dr Daniel Tillett
|
|
Bran
|
8 |
4.2K |
13 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
8
|
4.2K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Prof Borje Andersson to Chair Clinical Advisory Board
|
|
Bran
|
16 |
5.7K |
13 |
05/12/19 |
05/12/19 |
ASX - By Stock
|
16
|
5.7K
|
13
|
|
ASX - By Stock
|
RAC |
Re:
1993: 5 of a total of 7 (72%) patients achieved total eradication of their cancer (R/R AML)
|
|
Bran
|
29 |
12K |
5 |
29/11/19 |
29/11/19 |
ASX - By Stock
|
29
|
12K
|
5
|
|